Direct naar de inhoud
Interne Markt, Industrie, Ondernemerschap en Midden- en Kleinbedrijf

The substances and their values are presented in four separate lists.

A) Agreed EU-LCI values (December 2022) – substances with their established EU-LCI values and summary fact sheets (PDF, 330 kB)


B) Substances without EU-LCI values (December 2022) - will not be progressed until further data are available (PDF, 62 kB)


C) EU-LCI Master list (December 2022) - all the substances identified requiring an EU-LCI value (PDF, 276 kB)


D) EU-LCI Working list (December 2022) - substances currently being progressed (PDF, 80 kB)


If you want to know more about the background of the values, how they're derived and applied. See our EU-LCI value facts and information document.

Notes to the tables

  • EU-LCI ‘derived’ value: The EU-LCI value of a compound derived de novo using the EU-LCI protocol.
  • EU-LCI ‘ascribed’ value: The EU-LCI value given to a compound that has identical or very similar (differing by 20% or less) LCI values in the ANSES and AgBB lists